Hemoglobinuria in the Early Poststem-Cell-Transplant Period: Risk Factors and Association with Outcomes.

Kompotiatis, Panagiotis; Manohar, Sandhya; Alkhateeb, Hassan B; Hogan, William J; Nath, Karl A; Leung, Nelson

Kompotiatis, Panagiotis; Manohar, Sandhya; Alkhateeb, Hassan B; Hogan, William J; Nath, Karl A; Leung, Nelson.

Afiliação

Kompotiatis P; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Manohar S; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Alkhateeb HB; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Hogan WJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Nath KA; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Leung N; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Kidney360 ; 2(10): 1569-1575, 2021 10 28.

Article em En | MEDLINE | ID: mdl-35372983

Assuntos

Transplante de Células-Tronco Hematopoéticas; Hemoglobinúria; Adulto; Transplante de Células-Tronco Hematopoéticas/efeitos adversos; Hemoglobinúria/etiologia; Humanos; Estudos Retrospectivos; Fatores de Risco; Condicionamento Pré-Transplante/efeitos adversos

Palavras-chave

bone marrow transplant; clinical nephrology; fludarabine; hematopoietic stem cell transplantation; hemoglobinuria; lymphoma; peripheral blood stem cell; risk factors; stem cell transplantation; transplant

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Hemoglobinúria Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google